// App-Quantinova.ai

SAT0238 : VALIDATION OF THE ADJUSTED GLOBAL ANTIPHOSPHOLIPID SYNDROME SCORE AND CORRELATION WITH EXTRA-CRITERIA MANIFESTATIONS

Researchers

Presenter

  • O. Uludag

Principal Investigators

  • M. Bektas

  • E. Cene

  • Y. Yalinkaya

  • A. Gl

  • M. Inanc

  • M. L. Ocal

  • B. Artim-Esen

Medical Centers

  • Istanbul Faculty of Medicine, Istanbul University, Department of Internal Medicine, Istanbul, Turkey

  • Istanbul Faculty of Medicine, Division of Rheumatology, Department of Internal Medicine, Istanbul, Turkey

  • Yildiz Technical University, Department of Statistics, Istanbul, Turkey

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Autoimmune (AI)

Disease

  • Antiphospholipid syndrome

  • Pulmonary arterial hypertension

  • Dyslipidemia

  • Hypertension

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A